Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations
Prescription medications: Once dispensed or shipped, medications cannot be returned or refunded, except where required by law
BPC-157 + Recovery Supplements Peptides work best when supported by a strong nutritional and antioxidant foundation
Adequate hydration requires 8-10 glasses of water daily, with an additional 8 ounces for every gram of added fiber to prevent worsening constipation
Perfect for athletes, gym-goers, outdoor activities, or anyone looking to maintain hydration, this easy-to-mix powder delivers a delicious drink that can be enjoyed before, during, or after exercise
A Food and Drug Administration advisory committee voted to add BPC-157 to a drug compounding list -- a move that brings the popular peptide one step closer to being legally available to Americans with a prescription
)
